New Drugs Current Events | New Drugs News | 4
|
| Page
4 of
21 |
418 Results |
|
|
|
Sort By:
Page Views | Date |
Unique new scoring system can predict risk of death from cardiovascular disease
A unique new scoring system for assessing a patient's risk of death from cardiovascular disease is revealed in this week's BMJ. The score will help physicians determine a patient's need for drugs to reduce blood pressure (antihypertensive drugs) and other strategies for improving cardiovascular health. The score is based on information from eight... view more... (2001-07-11)
Athletes on performance enhancers more likely to abuse alcohol, other drugs
College athletes who use performance-enhancing substances may be at heightened risk of misusing alcohol and using recreational drugs as well, according to new research in the Journal of Studies on Alcohol and Drugs. view more (2009-11-12)
Researchers explore long-term adolescent vulnerability to drugs
As part of efforts to understand drug abuse, Georgia State University researchers are finding that adolescent rats appear to be less vulnerable to the long-term effects of withdrawal and relapse in certain types of drug use than rats that take the drugs in adulthood. view more (2009-09-17)
New findings show additional similarity between opiate and nicotine addiction
"That was good!" "Do it again." This is what the brain says when people use tobacco, as well as 'hard drugs' such as heroin. view more (2008-02-13)
Anti-malarials most effective in lupus patients genetically at risk of high levels of TNF-alpha
Anti-malarial drugs are most effective in people with lupus who are genetically predisposed to high levels of tumour necrosis factor alpha and low levels of the cytokine IL-10. view more (2006-02-13)
Diabetes targets will be impractical in routine practice
Targets due to be set as part of the national service framework for diabetes in England and Wales will be impractical for use in routine clinical care, according to an article in this week’s BMJ. view more (2002-06-26)
Synthetic molecules hold promise for new family of anti-cancer drugs
Synthetic molecules designed by two Hebrew University of Jerusalem researchers have succeeded in reducing and even eliminating the growth of human malignant tissues in mice, while having no toxic effects on normal tissue. view more (2008-06-05)
DOES TREATING HIGH BLOOD PRESSURE SAVE LIVES? (P1305)
Findings of a meta-analysis published in this week's issue of The Lancet emphasise that blood pressure control is important and that on average, all antihypertensive drugs have similar long-term efficacy and safety. One of the most common causes of death in the developed world is cardiovascular disease (heart attacks and strokes). Measures to... view more... (2001-10-17)
HIV drugs, Abacavir and Didanosine, increase the risk of heart attack
A study to assess the adverse effects of anti-retroviral drugs shows that two of the widely used HIV drugs are associated with an increased risk of heart attack/the formation of blood clots in the heart. With the use of Didanosine; the risk of developing a heart attack increases by 49%, with Abacavir; the increased risk is 90%. view more (2008-02-11)
New Paper from Internists Calls for Increased Role for FDA
A new policy paper that calls for broader authority and increased funding for the Food and Drug Administration (FDA) was released today by the American College of Physicians (ACP). Improving FDA Regulation of Prescription Drugs offers a half-dozen recommendations about how to improve the agency's ability to approve and monitor new drugs. view more (2009-09-25)
Anti-psychotic drugs could help fight cancer
The observation that people taking medication for schizophrenia have lower cancer rates than other people has prompted new research revealing that anti-psychotic drugs could help treat some major cancers. view more (2009-08-12)
Revolutionary new medical treatments: International effort to steer around obstacles
Major developments in biotech, genomics and stem cell research now offer exciting and far-reaching new opportunities for health care in conditions ranging from Alzheimer's and Parkinson's disease to genetic disorders. However the very pharmaceutical companies who could otherwise be expected to bring the relevant treatments to the market place are... view more... (2005-01-21)
Patients resistant to blood pressure treatment do take their drugs
Poor compliance with treatment is believed to be the most frequent reason why many patients with high blood pressure (hypertension) do not respond to drug treatment. However, a study in this week's BMJ finds no difference in compliance between treatment resistant and treatment responsive patients. Researchers at the University Hospital in Basle,... view more... (2001-07-18)
New method for examining cost-effectiveness of new drugs for chronic illnesses
In a comprehensive analysis and mathematical model of the available scientific data, researchers at the University of York on behalf of the National Institute of Health and Clinical Excellence (NICE) in the United Kingdom found that newer drugs used to treat the most common forms of epilepsy are more expensive than older drugs, but produce similar... view more... (2005-12-30)
Patients May Overestimate Risk Of Side-Effects From Qualitative Drug Information (p 853)
Authors of a research letter in this week's issue of THE LANCET are calling for EU guidelines to be reviewed after results of research which shows that patients only given qualitative information about the side-effects of drugs substantially overestimate their personal risk. To make informed decisions about taking medicinal drugs, people need... view more... (2002-03-06)
You are what you smoke
People use cannabis because it is part of their social identity, not just because they find it enjoyable, according to a paper in a symposium presented today, Saturday 31 March, to The British Psychological Society's Centenary Annual Conference, held at the SECC, Glasgow, by Professor Richard Hammersley of the University of Wales, Swansea.... view more... (2001-03-20)
New treatment shows promise against recurrent gynecologic cancers
Recurrent and metastatic endometrial and ovarian cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. view more (2009-04-22)
JDRF funded research shows promise for prevention, reversal of type 1 diabetes
Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. view more (2008-11-19)
Psychotropic drug prescriptions for teens surge 250 percent over 7 year period
Psychotropic drug prescriptions for teenagers skyrocketed 250 percent between 1994 and 2001, rising particularly sharply after 1999. view more (2006-01-04)
Some drugs increase risk of falling: UNC researchers
Researchers at the University of North Carolina at Chapel Hill have created a list of prescription drugs that increase the risk of falling for patients aged 65 and older who take four or more medications on a regular basis. view more (2008-07-10)
|
|
| Page
4 of
21 |
418 Results |
|
|
|
Sort By:
Page Views | Date |
|
